GILD

Gilead Sciences, Inc.

NASDAQHealthcareDrug Manufacturers - GeneralUS

USD128.99

+1.42 (+1.11%)

Rating:B+

Company Profile

CEO

Daniel O'Day

IPO Date

1992-01-22

Sector

Healthcare

Industry

Drug Manufacturers - General

Exchange

NASDAQ

Country

Market Metrics

Open

$127.59

Prev. Close

$127.57

Day Low

$127.50

Day High

$129.86

52W Low

$104.46

52W High

$157.29

Market Cap

$160.15B

Volume

6.21M

News SentimentBullish

Articles

Avg Positive

64.0%

Avg Negative

11.1%

Avg Neutral

25.1%

News Feed

Phase 3 ASSURE Interim Data: Majority of People in the Study with ALP 1--1.67×ULN Achieved High and Sustained Composite ALP Normalization at 24 Months with Gilead's Livdelzi (Seladelpar)

gurufocus.com·5/27/2026·↑ positive

Phase 3 ASSURE Interim Data: Majority of People in the Study with ALP 1–1.67×ULN Achieved High and Sustained Composite ALP Normalization at 24 Months with Gilead's Livdelzi (Seladelpar)

businesswire.com·5/27/2026·↑ positive